Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men
- 1 February 2004
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (3) , 447-457
- https://doi.org/10.1097/00002030-200402200-00011
Abstract
To study the genetic diversity of drug-resistant HIV strains present in blood and in semen, especially those archived in peripheral blood mononuclear cells (PBMC) and non-sperm cells (NSC). Paired blood and semen samples were collected from twenty heavily pre-treated HIV-infected men. HIV RNA in blood plasma (BP) and seminal plasma (SP), as well as proviral DNA in PBMC and NSC were quantified and used for resistance genotyping. Phylogenetic analysis of protease gene clones was used to explore the diversity of the viral quasi-species. Median BP HIV RNA, PBMC proviral DNA, SP HIV RNA and non-sperm cell proviral DNA loads were respectively: 4.77, 3.65, 3.16 and 1.77 log10 copies per ml or per 106 cells. Resistant HIV strains were found in the BP and PBMC of all the patients, in the SP of 14 patients, and in the NSC of five patients. Overall, the blood and genital compartments exhibited different genotypic resistance patterns in six patients (30%), with additional resistance mutations in the semen of four patients. Phylogenetic analysis of clones of HIV protease gene showed that viral strains in SP originated not only from passive diffusion from BP, but also from local production in semen. The storage of archived proviruses differed according to the anatomic reservoir. HIV resistant strains are frequent (70%) in the semen of heavily pre-treated men, and the diversity of genotypic resistance pattern confirms HIV compartmentalization. Thus, the risk of sexual transmission of resistant strains can only be partly predicted by standard tests applied to BP.Keywords
This publication has 40 references indexed in Scilit:
- Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in FranceAIDS, 2003
- Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapyAIDS, 2003
- Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral ExposureJournal of Virology, 2002
- The Pharmacokinetics of Amprenavir, Zidovudine, and Lamivudine in the Genital Tracts of Men Infected with Human Immunodeficiency Virus Type 1 (AIDS Clinical Trials Group Study 850)The Journal of Infectious Diseases, 2002
- Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlationsHIV Research & Clinical Practice, 2002
- Penetration of the Nucleoside Analogue Abacavir into the Genital Tract of Men Infected with Human Immunodeficiency Virus Type 1Clinical Infectious Diseases, 2001
- Pharmacokinetic Profiles of Nevirapine and Indinavir in Various Fractions of Seminal PlasmaAntimicrobial Agents and Chemotherapy, 2001
- Antiretroviral Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Protease from Paired Cerebrospinal Fluid and Plasma SamplesThe Journal of Infectious Diseases, 2000
- Nucleoside Analogues Achieve High Concentrations in Seminal Plasma: Relationship between Drug Concentration and Virus BurdenThe Journal of Infectious Diseases, 1999
- Detection Of Drug Resistance Mutations In The Human Immunodeficiency Virus Type I (HIV-I) pol Gene: Differences In Semen And Blood HIV-I RNA And Proviral DNAThe Journal of Infectious Diseases, 1994